Jay Venkatesan

Jay Venkatesan has an estimated net worth of $12.9 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., Targanta Therapeutics Corp., ALPINE IMMUNE SCIENCES, INC., Lion Biotechnologies, Inc., INSMED Inc, EXICURE, INC., Elicio Therapeutics, Inc., ACCESS PHARMACEUTICALS INC, and Serina Therapeutics, Inc..

2021 was Jay Venkatesan's most active year for acquiring shares with 15 total transactions. Jay Venkatesan's most active month to acquire stocks was the month of May. 2011 was Jay Venkatesan's most active year for disposing of shares, totalling 14 transactions. Jay Venkatesan's most active month to dispose stocks was the month of April. 2007 saw Jay Venkatesan paying a total of $7,083,612.75 for 2,796,682 shares, this is the most they've acquired in one year. In 2021 Jay Venkatesan cashed out on 1,441,996 shares for a total of $9,931,353.98, their largest year based on trade value.